Last reviewed · How we verify

NCT06670716: COGISTROKE

BRIEF COGNITIVE and DELIRIUM ASSESSMENTS in STROKE PATIENTS

Active, enrolled Last updated 25 February 2025
What this trial tests

trial testing Examination by a speech therapist in Stroke Acute in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
3 April 2024
Primary endpoint
3 May 2025
3 May 2026

Quick facts

Lead sponsorFaculty Hospital Kralovske Vinohrady
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment60
Start date3 April 2024
Primary completion3 May 2025
Estimated completion3 May 2026
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Faculty Hospital Kralovske Vinohrady

Who can join

Eligibility, any sex, with Stroke Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the project is to validate the ALBA and PICNIR tests for the easy detection of memory and speech disorders in patients after a stroke. Patients, after their first stroke, with the possibility of initial clinical evaluation within 24 hours of admission to the Neurology Clinic ICU, will undergo a neurological examination, cognitive tests using the ALBA and PICNIR tests, delirium tests using the CAM-ICU and ICDSC tools, and a speech therapy test using the MASTcz tool. If possible, these will be conducted simultaneously in one half-day. A similar structured examination will take place within five days, with a tolerance of one day. Upon demonstrating utility, doctors will be able to utilize the very brief ALBA and POBAV methods for detecting memory and speech disorders in post-stroke patients in clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke Acute

Currently open trials in the same condition.

Other Faculty Hospital Kralovske Vinohrady trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06670716.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing